Robert Lange Elliot Jr serves as Executive at OncBioMune Pharmaceuticals, Inc, where they oversee executive responsibilities. Since joining the company, Robert Lange Elliot Jr has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 2, 2015 involved selling 1,025,000 shares valued at $0.
Robert Lange Elliot Jr currently holds 16,926,079 shares of OncBioMune Pharmaceuticals, Inc (OBMP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Lange Elliot Jr has been a net neutral trader of OBMP stock. They have purchased $0 and sold $0 worth of shares.
Robert Lange Elliot Jr's most recent insider trade was on Sep 2, 2015, when they sold 1,025,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |